ContraFect Corporation (NASDAQ:CFRX) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS
ContraFect Corporation (NASDAQ:CFRX) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.07) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.18) by $0.11, Bloomberg Earnings reports.
ContraFect Corporation (NASDAQ CFRX) remained flat at $1.25 during midday trading on Thursday. The company had a trading volume of 42,576 shares. The company’s market cap is $52.07 million. ContraFect Corporation has a 12 month low of $1.10 and a 12 month high of $3.28. The firm’s 50-day moving average price is $1.34 and its 200-day moving average price is $1.62.
In other ContraFect Corporation news, Director Sol J. Barer acquired 40,000 shares of the business’s stock in a transaction dated Tuesday, July 25th. The stock was acquired at an average cost of $1.24 per share, for a total transaction of $49,600.00. Following the completion of the transaction, the director now directly owns 815,933 shares of the company’s stock, valued at $1,011,756.92. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders bought 50,800 shares of company stock valued at $62,992 over the last 90 days. Company insiders own 9.30% of the company’s stock.
Separately, Maxim Group reissued a “hold” rating on shares of ContraFect Corporation in a report on Wednesday, April 19th.
Receive News & Ratings for ContraFect Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.